Status:
COMPLETED
Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Lade Addiction Treatment Center
Conditions:
Alcoholism
Substance-Related Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This study is an assessment of the long-term effect of oxytocin nasal spray on alcohol withdrawal and dependence in adults admitted for detoxification of alcohol after 60 days and 1 year. It is a foll...
Eligibility Criteria
Inclusion
- participants in the RCT (NCT02903251) who completed the study
Exclusion
- participants in the RCT (NCT02903251) who did not complete the study
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2019
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03339024
Start Date
November 1 2017
End Date
March 31 2019
Last Update
February 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lade Addiction Treatment Center
Trondheim, Norway